The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A targeted drug therapy has shown potential to reverse cellular damage in Parkinson’s disease by regenerating critical brain structures and restoring neuron function, according to new findings from a ...

Scientists from the University of Copenhagen have uncovered a critical clue about what causes Parkinson’s disease, offering ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Learn more about the Hall of Famer’s health struggles, including his battle with Parkinson’s disease, & what is known about ...

Dave Parker, the iconic Pirates slugger, passed away at 74, just before his Hall of Fame induction. He battled Parkinson's ...